At DaVita, integrity is a fundamental part of the way we operate. We expect our business activities to be carried out responsibly, ethically, and in accordance with our internal policies as well as all relevant laws and regulations. These principles are reflected in our Code of Conduct and guide the decisions we make every day.

DaVita’s compliance program goes beyond simply meeting regulatory requirements. It is designed to help teammates recognize and uphold ethical standards in their daily work. During 2025, the company issued more than 300 compliance and ethics communications through approximately 30 different channels. More than 30 of these initiatives specifically addressed ethical leadership and the importance of making responsible choices.

Maintaining a strong ethical culture also depends on listening to employees and understanding their experiences. DaVita uses insights gathered through its annual engagement surveys and ethics culture assessments to identify areas of strength, improve leadership responsibility, and recognize employees who demonstrate exemplary ethical behavior. Outstanding individuals are acknowledged through the company’s Compliance Champion Awards.

This emphasis on integrity, accountability, and open communication provides the basis for DaVita’s wider responsibilities to the communities in which it operates. Two important areas of focus are Our Commitment to Human Rights and Training & Transparency.

Our Commitment to Human Rights

DaVita seeks to uphold human rights throughout its value chain, following the principles established by the UN Guiding Principles on Business and Human Rights. In 2022, the company engaged an independent consulting firm with expertise in human rights to conduct a comprehensive impact assessment. The objective was to identify potential human rights-related risks and opportunities associated with DaVita’s worldwide activities.

The assessment was conducted across the company’s operations, products and services, and entire supply chain. It involved a combination of background research, interviews with internal and external stakeholders, and an in-depth review of significant human rights issues and existing management practices.

Through this process, DaVita identified several important stakeholder groups within its value chain, including patients, teammates, third-party workers, suppliers, communities and wider society, and participants in clinical trials.

The findings from the assessment provide a framework for DaVita’s ongoing work to identify, address, and promote respect for human rights throughout its value chain.

Training & Transparency

Compliance education is an essential element of DaVita’s overall compliance framework. Every year, compliance training is required for teammates, guest teammates, medical directors, joint venture partners, and selected vendors and other third parties.

In 2025, DaVita continued its practice of evaluating employees’ understanding of compliance requirements after they completed the general compliance training program. The Compliance Department reviewed the results and used them to identify where additional, targeted education could strengthen individual employees’ knowledge and awareness.

In total, teammates completed more than 130,000 hours of compliance-related training during 2025.

Progress Report

2025 Outcomes

In 2021, DaVita established a set of ESG objectives intended to be achieved by 2025. Many of these targets were deliberately ambitious and represented long-term aspirations for the organization.

With the five-year period now complete, DaVita reports that it achieved or surpassed 19 of its 23 published ESG goals. The results demonstrate the collective effort and commitment of the company’s employees and broader community.

The following table summarizes the outcomes achieved against the ESG objectives established for the 2025 target year.